Listen to experts discuss the business practices of pharmaceutical companies in The Conversation Weekly podcast.
Academic rigour, journalistic flair
Articles on The business of pharmaceuticals
Displaying all articles
Moderna claims its scientists alone invented the mRNA sequence used to produce its COVID-19 vaccine. The US government, which helped fund the drug, disagrees.
Each dose of Pfizer has a long and complex path involving mixing, storage at temperatures colder than the South Pole and specific protocols that must be followed before it becomes a jab.
The COVID pandemic is giving drug companies an opportunity to reset their image. So how did they get so big and their credibility sink so low?
If Big Pharma wants to achieve the ultimate image makeover, it must capitalize on the current public good will about its COVID-19 vaccines by prioritizing socially responsible practices.
The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents altogether.
Top contributors
-
Assistant Professor, Bond University
-
Professor of Law, Villanova University
-
Professor of Technology and Operations, University of Michigan
-
Jérôme Caby is a Friend of The Conversation.
Professeur des Universités, IAE Paris – Sorbonne Business School
-
Professor of Philosophy, Binghamton University, State University of New York
-
Assistant Professor, School of Professional Communication, Toronto Metropolitan University
-
Associate Professor of History and Social Medicine, Florida State University
